Estrella Immunopharma, Inc.股价拉升11.42% 市值跌2.18万美元

市场透视2025-07-03

北京时间2025年07月03日03时56分，Estrella Immunopharma, Inc.（ESLA.us）股票出现波动，股价大幅拉升11.42%。截至发稿，该股报0.959美元/股，成交量9033股，换手率0.02%，振幅5.79%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.10百万美元，每股收益-0.06美元，毛利0.00美元，市盈率-2.99倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2548817137?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-03 03:56","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2548817137","market":"us","top_or_hot":-1,"title":"Estrella Immunopharma, Inc.股价拉升11.42% 市值跌2.18万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年07月03日03时56分，Estrella Immunopharma, Inc.（ESLA.us）股票出现波动，股价大幅拉升11.42%。截至发稿，该股报0.959美元/股，成交量9033股，换手率0.02%，振幅5.79%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.10百万美元，每股收益-0.06美元，毛利0.00美元，市盈率-2.99倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703035652a4cbbb7c&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Estrella Immunopharma, Inc.股价拉升11.42% 市值跌2.18万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEstrella Immunopharma, Inc.股价拉升11.42% 市值跌2.18万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-03 03:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703035652a4cbbb7c&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年07月03日03时56分，Estrella Immunopharma, Inc.（ESLA.us）股票出现波动，股价大幅拉升11.42%。截至发稿，该股报0.959美元/股，成交量9033股，换手率0.02%，振幅5.79%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.10百万美元，每股收益-0.06美元，毛利0.00美元，市盈率-2.99倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703035652a4cbbb7c&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ESLA","symbol_name":"Estrella Immunopharma","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703035652a4cbbb7c&s=b","article_id":"2548817137","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703035652a4cbbb7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2548817137","pubTimestamp":1751486212,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年07月03日03时56分，Estrella Immunopharma, Inc.股票出现波动，股价大幅拉升11.42%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ESLA":"Estrella Immunopharma","BK4139":"生物科技"},"translate_title":"Estrella Immunopharma, Inc. 's stock price rose 11.42%, market value fell by $21,800","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ESLA":1},"content_text":"北京时间2025年07月03日03时56分，Estrella Immunopharma, Inc.（ESLA.us）股票出现波动，股价大幅拉升11.42%。截至发稿，该股报0.959美元/股，成交量9033股，换手率0.02%，振幅5.79%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.10百万美元，每股收益-0.06美元，毛利0.00美元，市盈率-2.99倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)、Sonnet Biotherapeutics Holdings, Inc.、Nutriband Inc C/Wts (To Pur Com)涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为3882.13%、2110.79%、1364.28%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 (To Pur Com)、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为1154.51%、393.59%、256.20%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。 Estrella 的使命是利用人类免疫系统的进化力量来改变癌症和自身免疫性疾病患者的生活。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2548817137","isCrawlerRequest":true}